Impact of CYP2D6 inhibitors on tamoxifen metabolism in breast cancer patients

被引：0
|
作者：
Keller, Denise [1 ]
Medwid, Samantha [2 ]
Schwarz, Ute [2 ]
Legan, Robin [1 ]
Kim, Richard [2 ]
机构：
[1] London Hlth Sci Ctr, London, ON, Canada
[2] Univ Western Ontario, London, ON, Canada
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0065
引用
收藏
页码：250 / 253
页数：4
相关论文
共 50 条
  • [41] Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer
    Dezentje, Vincent O.
    Guchelaar, Henk-Jan
    Nortier, Johan W. R.
    van de Velde, Cornelis J. H.
    Gelderblom, Hans
    CLINICAL CANCER RESEARCH, 2009, 15 (01) : 15 - 21
  • [42] Clinical implications of CYP2D6 genotyping on tamoxifen treatment in breast cancer
    Dezentje, V. O.
    Nortier, J. W. R.
    Guchelaar, H. J.
    van de Velde, C. J. H.
    Gelderblom, H.
    EJC SUPPLEMENTS, 2008, 6 (07): : 56 - 56
  • [43] Tamoxifen Metabolite Concentrations, CYP2D6 Genotype, and Breast Cancer Outcomes
    Madlensky, L.
    Natarajan, L.
    Tchu, S.
    Pu, M.
    Mortimer, J.
    Flatt, S. W.
    Nikoloff, D. M.
    Hillman, G.
    Fontecha, M. R.
    Lawrence, H. J.
    Parker, B. A.
    Wu, A. H. B.
    Pierce, J. P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (05) : 718 - 725
  • [44] The frequencies of CYP2D6 alleles and their impact on clinical outcomes of adjuvant tamoxifen therapy in Syrian breast cancer patients
    Al-khalil, Wouroud Ismail
    Al-Salhi, Lana
    Rijjal, Sara
    Aljamali, Majd
    Youssef, Lama A.
    BMC CANCER, 2022, 22 (01)
  • [45] The frequencies of CYP2D6 alleles and their impact on clinical outcomes of adjuvant tamoxifen therapy in Syrian breast cancer patients
    Wouroud Ismail Al-khalil
    Lana Al-Salhi
    Sara Rijjal
    Majd Aljamali
    Lama A. Youssef
    BMC Cancer, 22
  • [46] Impact of CYP2D6 Genotype and Side-Effects on Adherence Rates to Tamoxifen in Premenopausal Breast Cancer Patients
    Hubalek, M.
    Oberguggenberger, A.
    Meraner, V.
    Beer, B.
    Giesinger, J.
    Oberacher, H.
    Sperner-Unterweger, B.
    Marth, C.
    CANCER RESEARCH, 2010, 70
  • [47] CYP2D6 Polymorphisms and Tamoxifen Metabolism: Clinical Relevance
    Higgins, Michaela J.
    Stearns, Vered
    CURRENT ONCOLOGY REPORTS, 2010, 12 (01) : 7 - 15
  • [48] CYP2D6 Polymorphisms and Tamoxifen Metabolism: Clinical Relevance
    Michaela J. Higgins
    Vered Stearns
    Current Oncology Reports, 2010, 12 : 7 - 15
  • [49] Understanding CYP2D6 and Its Role in Tamoxifen Metabolism
    Smith, Edith Caroline
    ONCOLOGY NURSING FORUM, 2013, 40 (06) : 547 - 548
  • [50] Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment
    Stingl, Julia Carolin
    Parmar, Sumit
    Huber-Wechselberger, Ariana
    Kainz, Alexander
    Renner, Wilfried
    Seeringer, Angela
    Brockmoeller, Juergen
    Langsenlehner, Uwe
    Krippl, Peter
    Haschke-Becher, Elisabeth
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (11) : 2535 - 2542
12345